US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ARK Genomic Revolution ETF

46.20

-1.4400-3.02%

Volume:419.36K

Turnover:19.57M

Market Cap:1.98B

PE:- -

High:47.28

Open:47.18

Low:46.13

Close:47.64

52wk High:50.54

52wk Low:24.20

Shares:42.75M

Float Shares:42.75M

Volume Ratio:1.32

T/O Rate:0.98%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Nippon Denko Boosts Core Earnings but Books Investment Loss, Plans New Mid‑Term Strategy

10x Genomics, Inc. : Stephens Raises Target Price to $65 from $50

THOMSON REUTERS

WAM Leaders outlines FY2026 results and SPP webinar details

Tempus AI CEO Data Ryan Fukushima Disposes of 20.000 Shares Worth $1 Juta

Absci Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Absci Q2 Loss Narrows, Revenue Declines

MT Newswires Live

Absci Merilis Presentasi Korporat Tentang Platform AI Generatif Untuk Penciptaan Obat Dan Pengembangan ABS-201 Untuk Kerontokan Rambut Pola

Absci Q2 Revenue Falls and Misses Analyst Expectations

Absci Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $318.000K Miss $1.169M Estimate

Benzinga Earnings

Twist Bioscience Director Robert Chess Disposes of Common Shares Worth $2.041.010,13

Absci Q2 Operating Income USD -34.158 Million

Absci Q2 Revenue USD 318 Thousand VS. Ibes Estimate USD 1.17 Million

THOMSON REUTERS

Absci Q2 Operating Expenses USD 34.476 Million

THOMSON REUTERS

Press Release: Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results

Forterra Confirms Total Voting Rights in Share Capital

Jiangsu Sidike New Materials Establishes Shanghai Subsidiary

MT Newswires Live

SpaceX Earnings Highlights from Cathie Wood's ARK Invest

Benzinga Earnings

10x Genomics Inc : Canaccord Genuity Raises Target Price to $60 from $50

THOMSON REUTERS

10x Genomics price target raised to $47 from $42 at Piper Sandler

NAC Co., Ltd. Issues Q1 FY2027 Results and Mid-Term Plan Overview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ARKG/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARKG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARKG\",,,,,undefined,":{"symbol":"ARKG","market":"US","secType":"STK","nameCN":"ARK Genomic Revolution ETF","latestPrice":46.2,"timestamp":1788184351273,"preClose":47.64,"halted":0,"volume":419357,"delay":0,"changeRate":-0.03022670025188912,"floatShares":42750000,"shares":42750000,"eps":0,"marketStatus":"Trading","change":-1.44,"latestTime":"08-31 09:52:31 EDT","open":47.18,"high":47.28,"low":46.13,"amount":19565455.611022,"amplitude":0.024139,"askPrice":46.2,"askSize":105,"bidPrice":46.19,"bidSize":105,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788206400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":47.64,"sharesOutstanding":39900000,"nav":49.847391,"aum":2041966154.75,"bidAskSpread":0.00024,"preHourTrading":{"tag":"盘前","latestPrice":46.99,"preClose":47.64,"latestTime":"09:29 EDT","volume":2595,"amount":122326.78451999999,"timestamp":1788182999999,"change":-0.65,"changeRate":-0.013644,"amplitude":0.013644},"postHourTrading":{"tag":"盘后","latestPrice":47.5673,"preClose":47.64,"latestTime":"19:53 EDT","volume":7917,"amount":376887.7414,"timestamp":1787961236204,"change":-0.0727,"changeRate":-0.001526,"amplitude":0.019102},"volumeRatio":1.318793,"impliedVol":0.4944,"impliedVolPercentile":0.3865},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARKG\",,,,,undefined,":{"symbol":"ARKG","floatShares":42750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.318793,"shares":42750000,"dividePrice":0,"high":47.28,"amplitude":0.024139,"preClose":47.64,"low":46.13,"week52Low":24.2,"pbRate":"--","week52High":50.535,"institutionHeld":0,"latestPrice":46.2,"eps":0,"divideRate":0,"volume":419357,"delay":0,"ttmEps":0,"open":47.18,"prevYearClose":28.97,"prevWeekClose":47.64,"prevMonthClose":38.56,"prevQuarterClose":42.06,"fiveDayClose":48.01,"twentyDayClose":39.62,"sixtyDayClose":36.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARKG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-29","symbol":"ARKG","amount":0.38239,"defaultRemindTime":1640788200000,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000},{"market":"US","date":"2020-12-29","symbol":"ARKG","amount":0.36456,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2020-12-31","payableDate":"2020-12-30","currency":"USD","type":"dividend","dateTimestamp":1609218000000},{"market":"US","date":"2019-12-27","symbol":"ARKG","amount":1.05395,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2019-12-31","payableDate":"2019-12-30","currency":"USD","type":"dividend","dateTimestamp":1577422800000},{"market":"US","date":"2018-12-27","symbol":"ARKG","amount":0.26999,"name":"ARK Genomic Revolution Multi-Sector ETF","recordDate":"2018-12-31","payableDate":"2018-12-28","currency":"USD","type":"dividend","dateTimestamp":1545886800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARKG\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2018-12-31","value":0.26999,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":1.05395,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.36456,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":0.38239,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARKG\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARKG\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658147923","title":"Nippon Denko Boosts Core Earnings but Books Investment Loss, Plans New Mid‑Term Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658147923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658147923?lang=en_us&edition=fundamental","pubTime":"2026-08-12 12:22","pubTimestamp":1786508536,"startTime":"0","endTime":"0","summary":"Nippon Denko Co., Ltd. ( ($JP:5563) ) has provided an announcement. Nippon Denko Co., Ltd. operates in the materials and ferroalloys industry, with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nippon-denko-boosts-core-earnings-but-books-investment-loss-plans-new-midterm-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nippon-denko-boosts-core-earnings-but-books-investment-loss-plans-new-midterm-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4544","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658923857","title":"10x Genomics, Inc. : Stephens Raises Target Price to $65 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2658923857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658923857?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:57","pubTimestamp":1786507046,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44903W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARKG","FMED","BK4585","BK4548","LU1861558580.USD","TXG","LU1861559042.SGD","BK4588","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658928662","title":"WAM Leaders outlines FY2026 results and SPP webinar details","url":"https://stock-news.laohu8.com/highlight/detail?id=2658928662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658928662?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:12","pubTimestamp":1786504351,"startTime":"0","endTime":"0","summary":"WAM Leaders Limited ( ($AU:WLE) ) has provided an announcement. WAM Leaders has released materials relating to its FY2026 full-year results and a S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/wam-leaders-outlines-fy2026-results-and-spp-webinar-details?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/wam-leaders-outlines-fy2026-results-and-spp-webinar-details?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4544","ARKG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946487","title":"Tempus AI CEO Data Ryan Fukushima Disposes of 20.000 Shares Worth $1 Juta","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946487","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946487?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:30","pubTimestamp":1786483817,"startTime":"0","endTime":"0","summary":"Tempus AI CEO Data Ryan Fukushima disposes of 20.000 shares worth $1 jutaTempus AI Inc.: Ryan Fukushima, CEO, Data, melaporkan penjualan 20.000 saham Class A pada 7 Agustus 2026.Saham dijual pada harg","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL65Rs5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI CEO Data Ryan Fukushima Disposes of 20.000 Shares Worth $1 Juta","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","TEMT","LU1861559042.SGD","LU1861558580.USD","TEM","ARKG","HEAL","BK4613","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658221945","title":"Absci Corp Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658221945","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658221945?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:01","pubTimestamp":1786482101,"startTime":"0","endTime":"0","summary":"Absci Corp reports results for the quarter ended June 30 - Earnings SummaryAbsci CorpABSI.OQreported a quarterly adjusted loss of 21 cents per share for the quarter ended June 30, higher than the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N448268:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ARKG","ABSI","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945660","title":"Absci Q2 Loss Narrows, Revenue Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945660","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945660?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:43","pubTimestamp":1786480982,"startTime":"0","endTime":"0","summary":"Absci  reported a Q2 net loss late Tuesday of $0.21 per share, narrowing from a loss of $0.24 a year earlier.Analysts polled by FactSet expected a loss of $0.19.Revenue for the quarter ended June 30 fell to $318,000 from $593,000 a year earlier.Analysts expected $900,000.Shares of Absci were down more than 13% in after-hours trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABSI","BK4121","ARKG","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658943272","title":"Absci Merilis Presentasi Korporat Tentang Platform AI Generatif Untuk Penciptaan Obat Dan Pengembangan ABS-201 Untuk Kerontokan Rambut Pola","url":"https://stock-news.laohu8.com/highlight/detail?id=2658943272","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658943272?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:30","pubTimestamp":1786480234,"startTime":"0","endTime":"0","summary":"Absci merilis presentasi korporat tentang platform AI generatif untuk penciptaan obat dan pengembangan ABS-201 untuk kerontokan rambut polaAbsci Corporation menegaskan fokus pada platform generatif AI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL39rVf7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ARKG","BK4121","BK4139","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658338943","title":"Absci Q2 Revenue Falls and Misses Analyst Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2658338943","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658338943?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:14","pubTimestamp":1786479256,"startTime":"0","endTime":"0","summary":"Absci Q2 revenue falls and misses analyst expectationsOverviewUS biopharma firm's Q2 revenue fell and missed analyst expectationsNet loss widened as R&D expenses rose due to advancing internal program","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ABSI","BK4539","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948748","title":"Absci Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $318.000K Miss $1.169M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948748","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948748?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:08","pubTimestamp":1786478921,"startTime":"0","endTime":"0","summary":"Absci (NASDAQ:ABSI) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.20) by 5 percent. This is a 12.5 percent increase over losses of $(0.24) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61126214/absci-q2-eps-0-21-misses-0-20-estimate-sales-318-000k-miss-1-169m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Absci Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $318.000K Miss $1.169M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ARKG","ABSI","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658419948","title":"Twist Bioscience Director Robert Chess Disposes of Common Shares Worth $2.041.010,13","url":"https://stock-news.laohu8.com/highlight/detail?id=2658419948","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658419948?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:06","pubTimestamp":1786478789,"startTime":"0","endTime":"0","summary":"Twist Bioscience Director Robert Chess disposes of common shares worth $2.041.010,13Direktur Robert Chess mengeksekusi opsi, memperoleh 18.417 saham Twist Bioscience pada harga USD 11,89 per saham.Pad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL7QKKdC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience Director Robert Chess Disposes of Common Shares Worth $2.041.010,13","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDNA","TWST","BK4588","GNOM","ARKG","BK4585","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948495","title":"Absci Q2 Operating Income USD -34.158 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948495","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948495?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:06","pubTimestamp":1786478761,"startTime":"0","endTime":"0","summary":"BRIEF-Absci Q2 Operating Income USD -34.158 MillionAug 11 (Reuters) - Absci Q2 net income USD -33.21 million.Q2 operating expenses USD 34.476 millionQ2 basic EPS USD -0.21Q2 revenue USD 318 thousand vs. IBES estimate USD 1.17 millionQ2 pretax profit USD -33.17 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLXP8JG9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABSI","ARKG","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948691","title":"Absci Q2 Revenue USD 318 Thousand VS. Ibes Estimate USD 1.17 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948691","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948691?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478702,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLXP8JG9N:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ABSI","BK4121","ARKG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948610","title":"Absci Q2 Operating Expenses USD 34.476 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948610?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478702,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLXP8JG9N:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ABSI","BK4539","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948282","title":"Press Release: Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948282","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948282?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478700,"startTime":"0","endTime":"0","summary":"Announced positive interim Phase 1 data from the HEADLINE trial of ABS-201Completed $100 million underwritten offering, including $40 million strategic investment from Eli Lilly & CompanyCash, cash equivalents, and marketable securities now sufficient to fund operations into the second half of 2028VANCOUVER, Wash. and NEW YORK, Aug. 11, 2026  -- Absci Corporation , a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today reported financial and operating results for the quarter ended June 30, 2026.\"The positive Phase 1 interim data from our HEADLINE trial, combined with our strengthened balance sheet and advancing platform, position us well for what comes next,\" said Sean McClain, Founder and CEO. \"We are fast approaching defining moments for Absci, with interim proof-of-concept data for pattern hair loss later this year and our full 26-week readout in early 2027. These results have the potential to demonstrate ABS-201's regenerat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","BK4099","PK","VTHR","BK4585","CHAT","BK4121","AIPO","KBWY","BK4139","BK4588","BK4604","BK4218","ARTY","03160","BK4181","AGIX","TM","QTOC","BK4555","BK4539","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658067996","title":"Forterra Confirms Total Voting Rights in Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2658067996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658067996?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:34","pubTimestamp":1786440859,"startTime":"0","endTime":"0","summary":"Forterra ( ($GB:FORT) ) has issued an announcement. Forterra plc operates in the U.K. building materials sector, manufacturing clay bricks, concret...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/forterra-confirms-total-voting-rights-in-share-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/forterra-confirms-total-voting-rights-in-share-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DVXB","FTIF","PAVE","BK4588","BK4585","BK4544","TSS","XLBI","ARKG","PKB","XLB","CCNR","EES","TRUM","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996796","title":"Jiangsu Sidike New Materials Establishes Shanghai Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996796","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658996796?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:48","pubTimestamp":1786430905,"startTime":"0","endTime":"0","summary":"Jiangsu Sidike New Materials Science & Technology (SHE:300806) established a wholly-owned subsidiary, Sidike Shanghai New Material Technology, with registered capital of 10 million yuan, according to ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300806","UYM","BK0220","BK4544","ARKG","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658958038","title":"SpaceX Earnings Highlights from Cathie Wood's ARK Invest","url":"https://stock-news.laohu8.com/highlight/detail?id=2658958038","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658958038?lang=en_us&edition=fundamental","pubTime":"2026-08-11 01:16","pubTimestamp":1786382210,"startTime":"0","endTime":"0","summary":"ARK Invest sees SpaceX stock selloff as short-term, as investors overlooked its $28.5 trillion total addressable market.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/08/61084513/spacex-earnings-highlights-from-cathie-woods-ark-invest","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKX","SPAL","ARKF","ARKQ","XOVR","SARK","ARKG","DXYZ","SNK","SPCX","ARKW","SPCU","ARKK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993450","title":"10x Genomics Inc : Canaccord Genuity Raises Target Price to $60 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993450","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993450?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:47","pubTimestamp":1786369626,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861559042.SGD","BK4548","BK4588","BK4585","TXG","ARKG","BK4121","LU1861558580.USD","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658388933","title":"10x Genomics price target raised to $47 from $42 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2658388933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658388933?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:20","pubTimestamp":1786360847,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on 10x Genomics (TXG) to $47 from $42 and keeps a Neutral rating on the shares following quarterly res...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/10x-genomics-price-target-raised-to-47-from-42-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/10x-genomics-price-target-raised-to-47-from-42-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1861559042.SGD","BK4588","BK4121","TXG","BK4548","ARKG","FMED","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658518985","title":"NAC Co., Ltd. Issues Q1 FY2027 Results and Mid-Term Plan Overview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658518985","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658518985?lang=en_us&edition=fundamental","pubTime":"2026-08-10 15:18","pubTimestamp":1786346315,"startTime":"0","endTime":"0","summary":"An announcement from NAC Co., Ltd. ( ($JP:9788) ) is now available. NAC Co., Ltd. released reference materials on its financial results for the fir...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nac-co-ltd-issues-q1-fy2027-results-and-mid-term-plan-overview?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nac-co-ltd-issues-q1-fy2027-results-and-mid-term-plan-overview?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NAC","BK4588","BK4544","ARKG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}